Novanta (NOVT) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for Novanta (NOVT) over the last 13 years, with Sep 2025 value amounting to $0.30.
- Novanta's EPS (Weighted Average and Diluted) fell 43.40% to $0.30 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.46, marking a year-over-year decrease of 12.05%. This contributed to the annual value of $1.77 for FY2024, which is 12.38% down from last year.
- According to the latest figures from Q3 2025, Novanta's EPS (Weighted Average and Diluted) is $0.30, which was up 150.00% from $0.12 recorded in Q2 2025.
- In the past 5 years, Novanta's EPS (Weighted Average and Diluted) registered a high of $0.63 during Q3 2022, and its lowest value of $0.12 during Q2 2025.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $0.45 (2024), whereas its average is $0.44.
- As far as peak fluctuations go, Novanta's EPS (Weighted Average and Diluted) surged by 65.79% in 2022, and later slumped by 68.42% in 2025.
- Quarterly analysis of 5 years shows Novanta's EPS (Weighted Average and Diluted) stood at $0.39 in 2021, then increased by 7.69% to $0.42 in 2022, then dropped by 19.05% to $0.34 in 2023, then spiked by 32.35% to $0.45 in 2024, then slumped by 43.40% to $0.30 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.30 in Q3 2025, compared to $0.12 in Q2 2025 and $0.59 in Q1 2025.